Esperion Therapeutics, Inc. (NASDAQ:ESPR) announced after the close Monday that the FDA has removed the peroxisome proliferator-activated receptor partial clinical hold on ETC-1002. On Thursday shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR) closed at $58.53. Company’s EPS growth for next 5 years is recorded as -3.10%.
Officials at Callon Petroleum Company (NYSE:CPE) said nearly 20 employees would be leaving its workforce through early retirement options offered by the company. CEO Fred Callon told The Natchez Democrat Wednesday the company decided to offer several employees, all of whom had 20 or more years with the company, an option to retire early as a way of reducing costs. Callon Petroleum Company (NYSE:CPE) in last trading activity increased 15.38% to close at $7.20. Company weekly performance is 33.58% while its quarterly performance stands at 22.87%. Callon Petroleum Company (NYSE:CPE) is -40.45% away from its 52 week high.
Taomee Holdings Limited (NYSE:TAOM) announced that its Board of Directors declared a special one-time cash dividend of US$0.0325 per ordinary share, or US$0.65 per American Depositary Share (“ADS”, each representing 20 ordinary shares), expects to pay out dividends to ADS holders on or around February 17, 2015. On last trading day Taomee Holdings Ltd. (NYSE:TAOM) increased 0.26% to close at $3.79. Its volatility for the week is 7.92% while volatility for the month is 5.06%. TAOM’s sales growth for past 5 years was 244.30% and its EPS growth for past 5 years was 56.90%. Taomee Holdings Ltd. (NYSE:TAOM) monthly performance is 15.90%.
Pfizer Inc (NYSE:PFE)’s $15 billion deal to buy Hospira Inc will allow the largest U.S. drugmaker to benefit from specialty generic medicines that are commanding far higher prices than traditional off-patent pills, industry investors and analysts said. On Thursday shares of Pfizer Inc. (NYSE:PFE) closed at $32.99. Company’s sales growth for last 5 years was 1.30% and EPS growth for next 5 years is recorded as 2.39%.
FTI Consulting, Inc. (NYSE:FCN) announced the appointment of Arnaud Salla as a Managing Director and Co-Head of the firm’s Strategic Communications segment in Paris. Mr. Salla will also lead the segment’s Capital Markets Communications offering in Europe, the Middle East and Africa (“EMEA”) within the Financial Communications practice. On last trading day FTI Consulting, Inc. (NYSE:FCN) increased 3.15% to close at $37.68. Its volatility for the week is 3.37% while volatility for the month is 2.84%. FCN’s sales growth for past 5 years was 5.00% and its EPS growth for past 5 years was -16.20%. FTI Consulting, Inc. (NYSE:FCN) monthly performance is 1.73%.